Warning: The NCBI web site requires JavaScript to function. more...
Nanotechnology-based drug delivery systems.
Suri SS, Fenniri H, Singh B.
J Occup Med Toxicol. 2007 Dec 1;2:16.
Related citations
Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
Bhaskar S, Tian F, Stoeger T, Kreyling W, de la Fuente JM, Grazú V, Borm P, Estrada G, Ntziachristos V, Razansky D.
Part Fibre Toxicol. 2010 Mar 3;7:3. Review.
Nanoparticles of biodegradable polymers for clinical administration of paclitaxel.
Feng SS, Mu L, Win KY, Huang G.
Curr Med Chem. 2004 Feb;11(4):413-24.
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
[Development of antituberculous drugs: current status and future prospects].
Tomioka H, Namba K.
Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.
Getting into the brain: approaches to enhance brain drug delivery.
Patel MM, Goyal BR, Bhadada SV, Bhatt JS, Amin AF.
CNS Drugs. 2009;23(1):35-58. doi: 10.2165/0023210-200923010-00003. Review.
Nanobiotechnology-based drug delivery to the central nervous system.
Jain KK.
Neurodegener Dis. 2007;4(4):287-91.
Brain targeting with surface-modified poly(D,L-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration.
Tahara K, Miyazaki Y, Kawashima Y, Kreuter J, Yamamoto H.
Eur J Pharm Biopharm. 2011 Jan;77(1):84-8. Epub 2010 Nov 11.
Chitosan nanoparticles: a promising system in novel drug delivery.
Nagpal K, Singh SK, Mishra DN.
Chem Pharm Bull (Tokyo). 2010;58(11):1423-30. Review.
Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters.
Gelperina S, Maksimenko O, Khalansky A, Vanchugova L, Shipulo E, Abbasova K, Berdiev R, Wohlfart S, Chepurnova N, Kreuter J.
Eur J Pharm Biopharm. 2010 Feb;74(2):157-63. Epub 2009 Sep 13.
Drug delivery systems. 1. site-specific drug delivery using liposomes as carriers.
Ranade VV.
J Clin Pharmacol. 1989 Aug;29(8):685-94. Review.
Functional polymeric nanoparticles: an efficient and promising tool for active delivery of bioactives.
Nahar M, Dutta T, Murugesan S, Asthana A, Mishra D, Rajkumar V, Tare M, Saraf S, Jain NK.
Crit Rev Ther Drug Carrier Syst. 2006;23(4):259-318. Review.
Disposition of nanoparticle-based delivery system via inner ear administration.
Chen G, Zhang X, Yang F, Mu L.
Curr Drug Metab. 2010 Dec;11(10):886-97. Review.
A review of multifunctional nanoemulsion systems to overcome oral and CNS drug delivery barriers.
Ganta S, Deshpande D, Korde A, Amiji M.
Mol Membr Biol. 2010 Oct;27(7):260-73. Epub 2010 Oct 7. Review.
PLGA/polymeric liposome for targeted drug and gene co-delivery.
Wang H, Zhao P, Su W, Wang S, Liao Z, Niu R, Chang J.
Biomaterials. 2010 Nov;31(33):8741-8. Epub 2010 Aug 19.
Design of a multifunctional PLGA nanoparticulate drug delivery system: evaluation of its physicochemical properties and anticancer activity to malignant cancer cells.
Wang Z, Chui WK, Ho PC.
Pharm Res. 2009 May;26(5):1162-71. Epub 2009 Feb 4.
Nanostructured materials for applications in drug delivery and tissue engineering.
Goldberg M, Langer R, Jia X.
J Biomater Sci Polym Ed. 2007;18(3):241-68. Review.
Pharmaceutical approaches to colon targeted drug delivery systems.
Chourasia MK, Jain SK.
J Pharm Pharm Sci. 2003 Jan-Apr;6(1):33-66. Review.
The potential for nanoparticle-based drug delivery to the brain: overcoming the blood-brain barrier.
Barbu E, Molnàr E, Tsibouklis J, Górecki DC.
Expert Opin Drug Deliv. 2009 Jun;6(6):553-65. Review.
Nanoparticles for direct nose-to-brain delivery of drugs.
Mistry A, Stolnik S, Illum L.
Int J Pharm. 2009 Sep 8;379(1):146-57. Epub 2009 Jun 23. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on